GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up

Background: GOLFIG is a chemo-immunotherapy regimen established in preclinical models that combines gemcitabine + FOLFOX (fluoropyrimidine backbone coupled to oxaliplatin) poly-chemotherapy with low-dose s. c. recombinant interleukin-2 (rIL-2) and granulocyte-macrophage colony stimulating factor (GM...

Descripción completa

Detalles Bibliográficos
Autores principales: Caraglia, Michele, Correale, Pierpaolo, Giannicola, Rocco, Staropoli, Nicoletta, Botta, Cirino, Pastina, Pierpaolo, Nesci, Antonello, Caporlingua, Nadia, Francini, Edoardo, Ridolfi, Laura, Mini, Enrico, Roviello, Giandomenico, Ciliberto, Domenico, Agostino, Rita Maria, Strangio, Alessandra, Azzarello, Domenico, Nardone, Valerio, Falzea, Antonella, Cappabianca, Salvatore, Bocchetti, Marco, D'Arrigo, Graziella, Tripepi, Giovanni, Tassone, Pierfrancesco, Addeo, Raffaele, Giordano, Antonio, Pirtoli, Luigi, Francini, Guido, Tagliaferri, Pierosandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857002/
https://www.ncbi.nlm.nih.gov/pubmed/31781481
http://dx.doi.org/10.3389/fonc.2019.01102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857002/
https://www.ncbi.nlm.nih.gov/pubmed/31781481
http://dx.doi.org/10.3389/fonc.2019.01102

Ejemplares similares